ESMO共识会议建议:局部区域黑色素瘤的管理
ESMO于2019年9月5-7日在阿姆斯特丹召开黑色素瘤共识会议,由32位多学科专家组成专家组,针对现有指南未详细涵盖或证据有限/矛盾的议题制定建议。本文呈现局部区域黑色素瘤管理的工作组建议、专家讨论及支持证据摘要,所有参与者批准最终文稿。
要点
- 共识会议聚焦局部区域黑色素瘤管理等五个议题。
- 建议基于工作组预先检索的文献制定并经全体投票。
- 本文汇总局部区域黑色素瘤的共识建议及支持证据。
核心结论
- 本文呈现ESMO共识会议关于局部区域黑色素瘤管理的共识建议及支持证据。
研究设计与样本
- ESMO于2019年9月5-7日在阿姆斯特丹召开共识会议,32位黑色素瘤管理多学科专家参会。
- 专家分五个工作组,预先检索相关科学文献,形成建议后提交全体讨论修改并投票。
主要发现
- 会议确定五个讨论主题,包括局部区域疾病管理、辅助治疗中靶向与免疫治疗比较等。
- 本文报告局部区域黑色素瘤管理的工作组建议、专家讨论及支持证据摘要。
临床怎么用
- 共识建议可供肿瘤内科医生在局部区域黑色素瘤管理决策中参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. The aim of the conference was to develop recommendations on topics that are not covered in detail in the current ESMO Clinical Practice Guideline and where available evidence is either limited or conflicting. The main topics identified for discussion were: (i) the management of locoregional disease; (ii) targeted versus immunotherapies in the adjuvant setting; (iii) targeted versus immunotherapies for the first-line treatment of metastatic melanoma; (iv) when to stop immunotherapy or targeted therapy in the metastatic setting; and (v) systemic versus local treatment of brain metastases. The expert panel was divided into five working groups in order to each address questions relating to one of the five topics outlined above. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel for further discussion and amendment before voting. This manuscript presents the results relating to the management of locoregional melanoma, including findings from the expert panel discussions, consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.
引用
- Michielin O, van Akkooi A, Lorigan P, et al. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol. 2020. PMID: 32763452. doi:10.1016/j.annonc.2020.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。